Matches in SemOpenAlex for { <https://semopenalex.org/work/W2011039869> ?p ?o ?g. }
- W2011039869 endingPage "909" @default.
- W2011039869 startingPage "888" @default.
- W2011039869 abstract "Tipranavir is a nonpeptidic protease inhibitor that has activity against human immunodeficiency virus strains resistant to multiple protease inhibitors. Tipranavir 500 mg is coadministered with ritonavir 200 mg. Tipranavir is metabolized by cytochrome P450 (CYP) 3A and, when combined with ritonavir in vitro, causes inhibition of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A in addition to induction of glucuronidase and the drug transporter P-glycoprotein. As a result, drug-drug interactions between tipranavir-ritonavir and other coadministered drugs are a concern. In addition to interactions with other antiretrovirals, tipranavir-ritonavir interactions with antifungals, antimycobacterials, oral contraceptives, statins, and antidiarrheals have been specifically evaluated. For other drugs such as antiarrhythmics, antihistamines, ergot derivatives, selective serotonin receptor agonists (or triptans), gastrointestinal motility agents, erectile dysfunction agents, and calcium channel blockers, interactions can be predicted based on studies with other ritonavir-boosted protease inhibitors and what is known about tipranavir-ritonavir CYP and P-glycoprotein utilization. The highly complex nature of drug interactions dictates that cautious prescribing should occur with narrow-therapeutic-index drugs that have not been specifically studied. Thus, the known interaction potential of tipranavir-ritonavir is reported, and in vitro and in vivo data are provided to assist clinicians in predicting interactions not yet studied. As more clinical interaction data are generated, better insight will be gained into the specific mechanisms of interactions with tipranavir-ritonavir." @default.
- W2011039869 created "2016-06-24" @default.
- W2011039869 creator A5023907922 @default.
- W2011039869 creator A5034242048 @default.
- W2011039869 date "2007-06-01" @default.
- W2011039869 modified "2023-09-26" @default.
- W2011039869 title "Mechanisms of Pharmacokinetic and Pharmacodynamic Drug Interactions Associated with Ritonavir-Enhanced Tipranavir" @default.
- W2011039869 cites W135804013 @default.
- W2011039869 cites W1502808108 @default.
- W2011039869 cites W1505525797 @default.
- W2011039869 cites W1510717844 @default.
- W2011039869 cites W1539825368 @default.
- W2011039869 cites W1559218836 @default.
- W2011039869 cites W1566726772 @default.
- W2011039869 cites W1596618344 @default.
- W2011039869 cites W1662165865 @default.
- W2011039869 cites W1708423019 @default.
- W2011039869 cites W1835540413 @default.
- W2011039869 cites W1926862327 @default.
- W2011039869 cites W1927129677 @default.
- W2011039869 cites W1965684140 @default.
- W2011039869 cites W1968583106 @default.
- W2011039869 cites W1971684396 @default.
- W2011039869 cites W1972286377 @default.
- W2011039869 cites W1974909111 @default.
- W2011039869 cites W1975396712 @default.
- W2011039869 cites W1975490782 @default.
- W2011039869 cites W1976589977 @default.
- W2011039869 cites W1976959607 @default.
- W2011039869 cites W1977926088 @default.
- W2011039869 cites W1978703735 @default.
- W2011039869 cites W1980643683 @default.
- W2011039869 cites W1980797008 @default.
- W2011039869 cites W1981719094 @default.
- W2011039869 cites W1985052140 @default.
- W2011039869 cites W1985765020 @default.
- W2011039869 cites W1985873090 @default.
- W2011039869 cites W1988520162 @default.
- W2011039869 cites W1991983405 @default.
- W2011039869 cites W1992738149 @default.
- W2011039869 cites W1997393178 @default.
- W2011039869 cites W200334173 @default.
- W2011039869 cites W2004576165 @default.
- W2011039869 cites W2006015481 @default.
- W2011039869 cites W2007788465 @default.
- W2011039869 cites W2008263033 @default.
- W2011039869 cites W2010933020 @default.
- W2011039869 cites W2011753619 @default.
- W2011039869 cites W2014617893 @default.
- W2011039869 cites W2014746876 @default.
- W2011039869 cites W2015554884 @default.
- W2011039869 cites W2015990374 @default.
- W2011039869 cites W2018464571 @default.
- W2011039869 cites W2022507089 @default.
- W2011039869 cites W2024189301 @default.
- W2011039869 cites W2025260112 @default.
- W2011039869 cites W2025685004 @default.
- W2011039869 cites W2026021678 @default.
- W2011039869 cites W2026582960 @default.
- W2011039869 cites W2030825392 @default.
- W2011039869 cites W2032120920 @default.
- W2011039869 cites W2033989658 @default.
- W2011039869 cites W2034666554 @default.
- W2011039869 cites W2039691068 @default.
- W2011039869 cites W2042390710 @default.
- W2011039869 cites W2043079423 @default.
- W2011039869 cites W2043527252 @default.
- W2011039869 cites W2043559003 @default.
- W2011039869 cites W2045131275 @default.
- W2011039869 cites W2045268724 @default.
- W2011039869 cites W2046080520 @default.
- W2011039869 cites W2047246548 @default.
- W2011039869 cites W2047890674 @default.
- W2011039869 cites W2048507000 @default.
- W2011039869 cites W2048865015 @default.
- W2011039869 cites W2051469662 @default.
- W2011039869 cites W2052344496 @default.
- W2011039869 cites W2052453482 @default.
- W2011039869 cites W2052494792 @default.
- W2011039869 cites W2058739178 @default.
- W2011039869 cites W2061866519 @default.
- W2011039869 cites W2063893944 @default.
- W2011039869 cites W2066183420 @default.
- W2011039869 cites W2066506506 @default.
- W2011039869 cites W2066735345 @default.
- W2011039869 cites W2067029715 @default.
- W2011039869 cites W2067436911 @default.
- W2011039869 cites W2067482824 @default.
- W2011039869 cites W2070050596 @default.
- W2011039869 cites W2070982932 @default.
- W2011039869 cites W2072212647 @default.
- W2011039869 cites W2072565182 @default.
- W2011039869 cites W2073995720 @default.
- W2011039869 cites W2075057316 @default.
- W2011039869 cites W2075257594 @default.
- W2011039869 cites W2075791349 @default.
- W2011039869 cites W2076404033 @default.
- W2011039869 cites W2077808362 @default.